| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |